Assessing Oncologists’ Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data

BACKGROUND: Despite national guideline recommendations for universal biomarker testing (KRAS, NRAS, BRAF, and mismatch repair and microsatellite instability [MMR/MSI]) in all patients with metastatic colorectal cancer (mCRC), little is known regarding adherence to these recommendations in routine pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Pritish, Deng, Mengying, Handorf, Elizabeth A, Nakhoda, Shazia, Dotan, Efrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664970/
https://www.ncbi.nlm.nih.gov/pubmed/36149298
http://dx.doi.org/10.1093/jncics/pkac065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664970/
https://www.ncbi.nlm.nih.gov/pubmed/36149298
http://dx.doi.org/10.1093/jncics/pkac065

Ejemplares similares